Establishing an appropriate level of vitamin D supplementation in paediatric patients with recessive dystrophic epidermolysis bullosa
Authors:
- 25 May 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 47 (7) , 1307-1313
Abstract
Paediatric patients with recessive dystrophic epidermolysis bullosa (RDEB) are at risk of vitamin D deficiency, owing to lack of sunlight from reduced mobility and having large areas of skin being covered with dressings, and to impaired nutritional intake and status. To establish an appropriate level of vitamin D supplementation in paediatric patients with RDEB. Patients with RDEB attending the EB tertiary multidisciplinary team clinic were enrolled. Serum levels of total 25(OH)D were retrospectively recorded for the study period 2012-2018. Data from clinical records on supplements, bone mineral density (BMD) Z scores, compliance, and use of enteral feeds and/or formula were also recorded. In total, 24 patients met the inclusion criteria: 20 with severe RDEB, 3 with RDEB inversa and 1 with intermediate RDEB. Of the 24 patients, 21 (88%) were advised to take a vitamin D3 supplement in line with Department of Health Guidelines (UK), with the remaining 3 patients receiving sufficient intake from formula or enteral feeds. Thirteen of the 24 (54%) had vitamin D deficiency or insufficiency despite advice to supplement; 9 of these 13 (69%) subsequently started or increased the dosage of vitamin D supplements and levels became sufficient (> 50 nmol/L), while the remaining 4 patients (31%) continued to have persistent insufficient levels due to noncompliance with supplements. Reasons for noncompliance were palatability, cost and forgetting to take the tablets. The dose required to maintain sufficient serum levels increased with age, up to 300% of the reference nutrient intake (RNI). All patients with RDEB require a supplement or a formula or enteral/sip feed containing vitamin D to maintain sufficient serum vitamin D. The dose required increases with age and can be up to three times higher than the RNI for the normal population. Compliance may improve using a once-weekly loading dose of vitamin D3. Vitamin D deficiency was not solely causative of a low BMD Z score.Keywords
This publication has 18 references indexed in Scilit:
- Vitamin D in adolescence: evidence-based dietary requirements and implications for public health policyProceedings of the Nutrition Society, 2017
- Vitamin D: Daily vs. Monthly Use in Children and Elderly—What Is Going On?Nutrients, 2017
- Birmingham epidermolysis severity score and vitamin D status are associated with low BMD in children with epidermolysis bullosaOsteoporosis International, 2016
- Vitamin D deficiency in Europe: pandemic?The American Journal of Clinical Nutrition, 2016
- Vitamin D in the Healthy European Paediatric PopulationJournal of Pediatric Gastroenterology and Nutrition, 2013
- Vitamin D and atopy and asthma phenotypes in childrenCurrent Opinion in Allergy and Clinical Immunology, 2012
- Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2011
- Bone mineralization in children with epidermolysis bullosaBritish Journal of Dermatology, 2006
- Vitamin and trace metal levels in recessive dystrophic epidermolysis bullosaJournal of the European Academy of Dermatology and Venereology, 2004
- Bone metabolism in children with epidermolysis bullosaThe Journal of Pediatrics, 2002